151 related articles for article (PubMed ID: 10134127)
1. Impact of a target drug monitoring program on the usage of clindamycin.
Gin AS; Lipinski LA; Honcharik N
Can J Hosp Pharm; 1994 Apr; 47(2):53-8. PubMed ID: 10134127
[TBL] [Abstract][Full Text] [Related]
2. Developing and implementing guidelines to promote appropriate use of fluconazole therapy in an AIDS clinic.
Anassi EO; Egbunike IG; Akpaffiong MJ; Ike EN; Cate TR
Hosp Pharm; 1994 Jun; 29(6):576-8, 581-2, 585-6. PubMed ID: 10134178
[TBL] [Abstract][Full Text] [Related]
3. A vancomycin drug use evaluation and economic analysis in a cancer treatment centre.
Dranitsaris G; Pilla NJ; McGreer A
Can J Hosp Pharm; 1994 Apr; 47(2):59-64. PubMed ID: 10134128
[TBL] [Abstract][Full Text] [Related]
4. The economic impact of clinical pharmacists' unsolicited recommendations.
Torok N; Brown G
Hosp Pharm; 1992 Dec; 27(12):1052-3, 1056-8, 1060. PubMed ID: 10122507
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic surveillance: the results of a clinical pharmacy intervention program.
Capers CC; Bess DT; Branam AC; Falbe WJ; Mrochek SA; Haymond JD; Stahl AA
Hosp Pharm; 1993 Mar; 28(3):206-10, 212. PubMed ID: 10124947
[TBL] [Abstract][Full Text] [Related]
6. Drug utilization & therapeutic intervention programs: pharmacy services that pay for themselves.
Condron JH; Mann JL
Can J Hosp Pharm; 1994 Oct; 47(5):203-8. PubMed ID: 10137698
[TBL] [Abstract][Full Text] [Related]
7. A strategy to reduce drug expenditures with a drug utilization review program.
Hoffmann RP
Hosp Pharm; 1984 Jan; 19(1):7-8, 11-2. PubMed ID: 10264746
[TBL] [Abstract][Full Text] [Related]
8. Benefits of clinical pharmacy services in a community hospital.
Williams LE
Hosp Pharm; 1993 Aug; 28(8):759-63, 766-7. PubMed ID: 10127576
[TBL] [Abstract][Full Text] [Related]
9. The impact of a pharmacist-managed dosage form conversion service on ciprofloxacin usage at a major Canadian teaching hospital: a pre- and post-intervention study.
Ho BP; Lau TT; Balen RM; Naumann TL; Jewesson PJ
BMC Health Serv Res; 2005 Jun; 5():48. PubMed ID: 15987523
[TBL] [Abstract][Full Text] [Related]
10. Focus and impact of pharmacists' interventions.
Strong DK; Tsang GW
Can J Hosp Pharm; 1993 Jun; 46(3):101-8. PubMed ID: 10126864
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of an antibiotic cost containment measure.
Jung B; Andrews JD
Can J Hosp Pharm; 1990 Jun; 43(3):116-22. PubMed ID: 10105649
[TBL] [Abstract][Full Text] [Related]
12. A practical approach to achieving a $950,000 cost savings from a joint anesthesia-pharmacy program.
Durfee DD
Hosp Pharm; 1995 Nov; 30(11):957-8, 961-3. PubMed ID: 10152916
[TBL] [Abstract][Full Text] [Related]
13. Target drug monitoring: a cost-effective service provided by staff pharmacists.
Chrymko MM; Meyer JD; Kelly WN
Hosp Pharm; 1994 Apr; 29(4):347, 350-2. PubMed ID: 10133463
[TBL] [Abstract][Full Text] [Related]
14. The effect of pharmacy intervention on aminoglycoside costs.
Tsuyuki RT; Nakagawa RS
Can J Hosp Pharm; 1987 Apr; 40(2):51-6. PubMed ID: 10282090
[TBL] [Abstract][Full Text] [Related]
15. Department of pharmacy-initiated program for streamlining empirical antibiotic therapy.
Pastel DA; Chang S; Nessim S; Shane R; Morgan MA
Hosp Pharm; 1992 Jul; 27(7):596-603, 614. PubMed ID: 10119188
[TBL] [Abstract][Full Text] [Related]
16. Use of staff pharmacists to reduce the inappropriate use of parenteral histamine-2 antagonist therapy.
Caldwell RD; Davis SK
Hosp Pharm; 1987 Dec; 22(12):1205-9. PubMed ID: 10285375
[TBL] [Abstract][Full Text] [Related]
17. Drug utilization review of parenteral clindamycin therapy.
Martinez DR; Reitz JA; Miller WA; Nolly RJ
Hosp Formul; 1984 Apr; 19(4):308-16. PubMed ID: 10265843
[TBL] [Abstract][Full Text] [Related]
18. Controlling moxalactam and cefotaxime use with a target drug program.
Abramowitz PW; Ludwig DJ; Mansur JM; Nold EG
Hosp Pharm; 1983 Aug; 18(8):416-20. PubMed ID: 10261791
[TBL] [Abstract][Full Text] [Related]
19. Impact of a pharmacist/physician cooperative target drug monitoring program on prophylactic antibiotic prescribing in obstetrics and gynecology.
Michael KA; Henderson PL; Newman RB; Blackwelder EN; Caldwell RD
Hosp Pharm; 1992 Mar; 27(3):213-6. PubMed ID: 10116721
[TBL] [Abstract][Full Text] [Related]
20. Impact of a clinical pharmacist on cost saving and cost avoidance in drug therapy in an intensive care unit.
Chuang LC; Sutton JD; Henderson GT
Hosp Pharm; 1994 Mar; 29(3):215-8, 221. PubMed ID: 10132696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
